In contrast to these findings in ovarian cancers, two in vitro studies on breast or prostate cancer cells suggested a tumor-suppressive role of ERRβ (Madhu Krishna et al. 2018; Yu et al. 2008). Here, ESRRB is linked to prostate cancer.